MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517059879 A) filed by Rewind Therapeutics NV, Heverlee, Belgium, on June 23, for 'fused pyrrolyl-sulfonamide compounds.'
Inventor(s) include Pinto, Rui Miguel Garcia Costa; Duvey, Guillaume Albert Jacques; Vanherck, Jean-Christophe Andre Louis; Marchand, Arnaud Didier Marie; and Pericolle, Vincent Henri Denis.
The application for the patent was published on July 4, under issue no. 27/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to a compound of formula (I), or a tautomer, a stereoisomer, a hydrate, a solvate, a polymorph, a prodrug, an isotope, or a co-crystal thereof, or a pharmaceutically acceptable salt thereof, (I) wherein A, R1, and R2 are as defined in the description and claims. The present invention also relates to a pharmaceutical composition comprising a compound according to the invention, and a pharmaceutical acceptable carrier. The present invention also relates to the present compounds for use as a medicine and/or as diagnostics. The present invention also relates to the present compounds for use in the prevention and/or treatment of GPR17 mediated disorders, such as for example a disorder or syndrome selected from a myelination disorder and a disorder or syndrome associated with brain tissue damage."
The patent application was internationally filed on Dec. 01, 2023, under International application No.PCT/EP2023/083917.
Disclaimer: Curated by HT Syndication.
